| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Annals of Surgical Oncology, Vol 5, Issue 1 23-27, Copyright © 1998 by Society of Surgical Oncology
ARTICLES |
E. R. Port, L. K. Tan, P. I. Borgen and K. J. Van Zee
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
BACKGROUND: We investigated the incidence of axillary lymph node metastases in patients with T1a (< or = 0.5 cm) and T1b (> 0.5 cm and < or = 1.0 cm) breast cancers. METHODS: The charts of 2000 patients who underwent axillary lymph node dissection for breast cancer at our institution from 1989 to 1991 were reviewed. Of these, 81 patients had T1a and 166 had T1b primary breast cancers. RESULTS: Among the 247 patients with T1a and T1b breast cancers, nodal metastases were present in 30 (12.1%), with a 7.4% positivity rate for patients with T1a and 14.5% positivity rate for T1b tumors. Of the 212 patients who had > or = 10 nodes dissected, 29 (13.7%) had positive nodes. Of those, 6 of 60 (10.0%) patients with T1a and 23 of 152 (15.1%) with T1b tumors had positive nodes. The presence of lymphovascular invasion (LVI) predicted a significantly higher nodal positivity rate (27.8% vs. 10.9%, p = 0.05). CONCLUSIONS: Of patients with adequately evaluated axillae, 10% with T1a and 15% with T1b cancers were found to have nodal metastases. Although LVI was significantly associated with a higher risk of lymph node metastases, we could not characterize any subgroup at acceptably low risk of nodal positivity. Until a more useful prognostic indicator is discovered, axillary dissection should continue to be part of the mainstay of management for small breast cancers.
This article has been cited by other articles:
![]() |
J. L. B. Bevilacqua, M. W. Kattan, J. V. Fey, H. S. Cody III, P. I. Borgen, and K. J. Van Zee Doctor, What Are My Chances of Having a Positive Sentinel Node? A Validated Nomogram for Risk Estimation J. Clin. Oncol., August 20, 2007; 25(24): 3670 - 3679. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Smidt, D. M. Kuster, G. J. van der Wilt, F. B. Thunnissen, K. J. Van Zee, and L. J. A. Strobbe Can the Memorial Sloan-Kettering Cancer Center Nomogram Predict the Likelihood of Nonsentinel Lymph Node Metastases in Breast Cancer Patients in The Netherlands? Ann. Surg. Oncol., December 1, 2005; 12(12): 1066 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Chao, M.-F. Chen, C.-S. Wang, Y.-Y. Jan, T.-L. Hwang, and S.-C. Chen Small Invasive Breast Carcinomas in Taiwanese Women Ann. Surg. Oncol., August 1, 2003; 10(7): 740 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fisher, J.-H. Jeong, S. Anderson, J. Bryant, E. R. Fisher, and N. Wolmark Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation N. Engl. J. Med., August 22, 2002; 347(8): 567 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chen, S. Palleschi, A. Khoynezhad, G. Gecelter, C. P. Marini, and H. H. Simms Role of Primary Breast Cancer Characteristics in Predicting Positive Sentinel Lymph Node Biopsy Results: A Multivariate Analysis Arch Surg, May 1, 2002; 137(5): 606 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Mincey, T. Bammer, E. J. Atkinson, and E. A. Perez Role of Axillary Node Dissection in Patients With T1a and T1b Breast Cancer: Mayo Clinic Experience Arch Surg, July 1, 2001; 136(7): 779 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Kamath, R. Giuliano, E. L. Dauway, A. Cantor, C. Berman, N. N. Ku, C. E. Cox, and D. S. Reintgen Characteristics of the Sentinel Lymph Node in Breast Cancer Predict Further Involvement of Higher-Echelon Nodes in the Axilla: A Study to Evaluate the Need for Complete Axillary Lymph Node Dissection Arch Surg, June 1, 2001; 136(6): 688 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Reynolds, R. Mick, J. H. Donohue, C. S. Grant, D. R. Farley, L. S. Callans, S. G. Orel, G. L. Keeney, T. J. Lawton, and B. J. Czerniecki Sentinel Lymph Node Biopsy With Metastasis: Can Axillary Dissection Be Avoided in Some Patients With Breast Cancer? J. Clin. Oncol., June 1, 1999; 17(6): 1720 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liberman, H. S. Cody III, A. D. K. Hill, P. P. Rosen, S. D. J. Yeh, T. Akhurst, E. A. Morris, A. F. Abramson, P. I. Borgen, and D. D. Dershaw Sentinel Lymph Node Biopsy after Percutaneous Diagnosis of Nonpalpable Breast Cancer Radiology, June 1, 1999; 211(3): 835 - 844. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |